Leptomeningeal metastasis: MR imaging.

Abstract

Seven patients with central nervous system neoplasia and leptomeningeal metastases, proved either at initial diagnosis or on follow-up with contrast material-enhanced computed tomography (CT), were evaluated with magnetic resonance (MR) imaging. In two patients, diffuse sulcal enhancement on CT scans was inapparent on T1- or T2-weighted MR images. Likewise, in four patients diffuse cisternal enhancement on CT scans was not identifiable with MR. Nodular or focal cisternal masses were identified with both CT and MR imaging in three patients; in two, however, MR imaging provided less information. Ependymal and subependymal metastases identified with CT (two patients) were indistinguishable on MR images from periventricular abnormalities of radiation therapy and/or hydrocephalus. These findings suggest that leptomeningeal metastasis may be so subtle or inapparent as to be overlooked with MR imaging alone. Thus, CT and MR imaging should be considered complementary techniques for initial diagnosis and follow-up of tumors with a propensity for leptomeningeal metastasis.

Spinal Leptomeningeal Neoplastic Disease

“…lb, c). Enhancement and consecutive increase in signal intensity in T r weighted sequences is dependent on a combination of blood-brain barrier breakdown and intact spinal vascular supply [2,25],…”

Leptomeningeal Carcinomatosis: A Report of 3 Cases and Review of the Literature

“…Unenhanced M R I may offer even a higher yield o f false-negative results and reveals a definite abnormality only in 27% of patients with positive myelograms [31]. However, gado linium-enhanced M RI is reported to produce a sensitivity as high as 66% in the diagnosis o f carcinomatous menin gitis and should be performed in any suspected case [30.…”

MR imaging of experimental meningeal melanomatosis in nude rats

“…It is more sensitive than contrast enhanced CT of the brain and equally sensitive as myelography in detection of spinal seeding [7][8][9]. Smaller lesions, however, may be inapparent and the distinction may be difficult between enhancing tumor lesions and enhancement due to non-specific blood-brain and blood-CSF barrier disturbances.…”